Stephanie E Reitsma
Overview
Explore the profile of Stephanie E Reitsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehic D, Reitsma S, de Moreuil C, Haslacher H, Koeller M, de Laat B, et al.
Blood Adv
. 2024 Sep;
8(21):5663-5673.
PMID: 39231312
Bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion after evaluation of plasma coagulation and platelet function. Patients with BDUC (n = 375) recorded in the Vienna Bleeding...
2.
Schramm T, Rast J, Mehic D, Reitsma S, de Moreuil C, Fillitz M, et al.
J Thromb Haemost
. 2024 Aug;
22(11):3209-3220.
PMID: 39214313
Background: Patients with primary immune thrombocytopenia (ITP) have an increased risk of thrombosis, which may be due to altered fibrinolysis. Objectives: To elucidate the clinical impact of delayed fibrinolysis in...
3.
Reitsma S, Ahmadzia H, Wolberg A
Am J Obstet Gynecol
. 2024 Jul;
232(2):e50.
PMID: 39074681
No abstract available.
4.
Reitsma S, Barsoum J, Hansen K, Sassin A, Dzieciatkowska M, James A, et al.
Am J Obstet Gynecol
. 2024 May;
232(2):220.e1-220.e18.
PMID: 38710264
Background: Postpartum hemorrhage is difficult to predict, is associated with significant maternal morbidity, and is the leading cause of maternal mortality worldwide. The identification of maternal biomarkers that can predict...
5.
Reitsma S, Holle L, Bouck E, Monroe D, Mast A, Burthem J, et al.
J Thromb Haemost
. 2023 Jan;
21(3):467-479.
PMID: 36696199
Background: Factor (F) XI deficiency is associated with increased bleeding risk in some individuals. Neither FXI levels nor clinical clotting assays predict the bleeding risk. Compared with controls, FXI-deficient bleeders...
6.
Zheng T, Kohs T, Mueller P, Pang J, Reitsma S, Parra-Izquierdo I, et al.
Blood Adv
. 2022 Oct;
7(8):1366-1378.
PMID: 36219587
Low-density lipoprotein (LDL) contributes to atherogenesis and cardiovascular disease through interactions with peripheral blood cells, especially platelets. However, mechanisms by which LDL affects platelet activation and atherothrombosis, and how to...
7.
Zheng T, Parra-Izquierdo I, Reitsma S, Heinrich M, Larson M, Shatzel J, et al.
Am J Physiol Cell Physiol
. 2022 Aug;
323(4):C1231-C1250.
PMID: 35938677
Tyrosine kinase inhibitors (TKIs) have emerged as a promising class of target-directed, small molecule inhibitors used to treat hematologic malignancies, inflammatory diseases, and autoimmune disorders. Recently, TKIs have also gained...
8.
Lakshmanan H, Estonilo A, Reitsma S, Melrose A, Subramanian J, Zheng T, et al.
J Thromb Haemost
. 2022 Mar;
20(6):1350-1363.
PMID: 35352494
Background: Biochemical reaction networks are self-regulated in part due to feedback activation mechanisms. The tissue factor (TF) pathway of blood coagulation is a complex reaction network controlled by multiple feedback...
9.
Reitsma S, Lakshmanan H, Johnson J, Pang J, Parra-Izquierdo I, Melrose A, et al.
Am J Physiol Cell Physiol
. 2022 Jan;
322(3):C370-C381.
PMID: 35080922
Cannabis usage has steadily increased as acceptance is growing for both medical and recreational reasons. Medical cannabis is administered for treatment of chronic pain based on the premise that the...
10.
Parra-Izquierdo I, Lakshmanan H, Melrose A, Pang J, Zheng T, Jordan K, et al.
Front Immunol
. 2021 Sep;
12:729951.
PMID: 34527000
Circulating platelets establish a variety of immunological programs and orchestrate inflammatory responses at the endothelium. Platelets express the innate immunity family of Toll-like receptors (TLRs). While TLR2/TLR1 ligands are known...